mechanism of action for glp 1 receptor agonists Glucagon-like peptide agonists: cardiovascular benefits and mechanisms “Weighing In” on GLP-1 Receptor

Efpeglenatide and cardiovascular outcomes in type 2 diabetes

24 Cosmetics/Beauty and Wellness Industry: The psychological impact of the change could have a similar impact on the cosmetic/beauty industry, with a Piper Sandler analyst recently highlighting that the broader awareness for appearance could be a tailwind. 25 5: Reduction in Average Weight A reduction in average weight across the population could also have widespread impact across several industries

PMID: 7592866

Because medications for type 2 diabetes may be taken for many years, if GLP-1based therapy did induce low-grade asymptomatic pancreatitis, there is a real concern that such a therapy might increase the risk for pancreatic cancer

Statements Author contributions IZ, MP, GA, FG, VC, AS, and FA participated in the study conceptualization

These side effects typically occur during the initiation of the medication or during dose escalation